JPRN-UMIN000023232已完成未知
The comparison of the characteristics of Japanese SCCmec type II and type IV MRSA. - The characteristics of Japanese SCCmec type II and type IV MRSA
Department of General Internal Medicine, Kyushu University Hospital0 个研究点目标入组 280 人开始时间: 2016年7月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 280
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients who were treated at the neonatal intensive care unit or growing care unit
研究者
相似试验
已完成
不适用
A preliminary study on the sole sense of Japanese and ThaiJPRN-UMIN000027687Kao Corporation60
未知
1 期
A Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Patients With Castration-Resistant Prostate CancerChemotherapy-naive castration-resistant prostate cancerJPRN-jRCT2080221877Takeda Pharmaceutical Company Limited72
进行中（未招募）
1 期
Study to find out the effects and fate of treatment with Orteronel plus prednisone in Japanese and non Japanese people that have not recieved cancer therapy for prostate cancer.progressive castration-resistant prostate cancer.MedDRA version: 14.1Level: SOCClassification code 10029104Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-001539-30-NLMillennium Pharmaceuticals, Inc.144
已完成
2 期
A Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naïve Patients With Castration-Resistant Prostate Cancercastrationresistant prostate cancer (mCRPC)chemotherapy-naïvemetastaticprogressiveprostate cancer1003859310036958NL-OMON37312Millenium Pharmaceuticals8
进行中（未招募）
1 期
Study to find out the effects and fate of treatment with Orteronel plus prednisone in Japanese and non Japanese people that have not recieved cancer therapy for prostate cancer.progressive castration-resistant prostate cancer.MedDRA version: 14.1Level: SOCClassification code 10029104Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-001539-30-GRMillennium Pharmaceuticals, Inc.144